Advancing comparative studies of patterns of care and economic outcomes in cancer: Challenges and opportunities

Journal of the National Cancer Institute - Monographs

Volumn , Issue 46, 2013, Pages 1-6

  Yabroff, K Robin ^a   Francisci, Silvia ^b   Mariotto, Angela ^a   Mezzetti, Maura ^c   Gigli, Anna ^d   Lipscomb, Joseph ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d CNR   (Italy)

^e EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; COLORECTAL CANCER; COMPARATIVE STUDY; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MEDICARE; MORTALITY; NEOPLASM; PATIENT CARE; PRIORITY JOURNAL; SCREENING; SYSTEMATIC REVIEW (TOPIC); UTERINE CERVIX CANCER; ECONOMICS; FEMALE; HEALTH SERVICES RESEARCH; MALE; ORGANIZATION AND MANAGEMENT; TREATMENT OUTCOME; NEOPLASMS;

DELIVERY OF HEALTH CARE; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; MALE; NEOPLASMS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE);

EID: 84883021531     PISSN: 10526773     EISSN: 17456614     Source Type: Book Series    
DOI: 10.1093/jncimonographs/lgt005     Document Type: Article

References (43)

1. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-2917.
2. Sullivan R, Peppercorn J, Sikora K, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol. 2011;12(10):933-980.
3. Howlader NA, Krapcho M, Neyman N, et al., eds. SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute, 2011. http://seer.cancer.gov/csr/1975_2008.
4. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18(3):581-592.
5. Lutz JM, Francisci S, Mugno E, et al. Cancer prevalence in Central Europe: the EUROPREVAL Study. Ann Oncol. 2003;14(2):313-322.
6. Mariotto AB, YabroffKR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103(2):117-128.
7. Capocaccia R, Colonna M, Corazziari I, et al. Measuring cancer prevalence in Europe: the EUROPREVAL Project. Ann Oncol. 2002;13(6):831-839.
8. AIRTUM Working Group. Italian cancer figures, report 2010: cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients. Epidemiol Prev. 2010;34(5-6 suppl 2):1-188.
9. Bradley CJ, Lansdorp-Vogelaar I, YabroffKR, et al. Projected productivity savings from colorectal cancer prevention and control strategies. Am J Prev Med. 2011;41(2):e5-e14.
10. Bradley CJ, YabroffKR, Dahman B, Feuer EJ, Mariotto A, Brown ML. Productivity costs of cancer mortality in the United States: 2000-2020. J Natl Cancer Inst. 2008;100(24):1763-1770.
11. YabroffKR, Bradley CJ, Mariotto AB, Brown ML, Feuer EJ. Estimates and projections of value of life lost from cancer deaths in the United States. J Natl Cancer Inst. 2008;100(24):1755-1762.
12. Elkin EB, Bach PB. Cancer's next frontier: addressing high and increasing costs. JAMA. 2010;303(11):1086-1087.
13. Bach PB. Limits on Medicare's ability to control rising spending on cancer drugs [published correction appears in N Engl J Med. 2009:360(9):944]. N Engl J Med. 2009;360(6):626-633.
14. OECD Health Data 2012. Organisation for Economic Co-operation and Development (OECD) Web site. http://www.oecd.org/health/health-systems/oecdhealthdata2012.htm. Accessed January 3, 2013.
15. Organisation for Economic Co-operation and Development (OECD). Health at a Glance 2011: OECD Indicators. Paris, France: OECD Publishing; 2011. http://dx.doi.org/10.1787/health_glance-2011-en. Accessed December 27, 2012.
16. Fuchs VR. How and why US health care differs from that in other OECD countries. JAMA. 2013;309(1):33-34.
17. National Research Council and Institute of Medicine. U.S. Health in International Perspective: Shorter Lives, Poorer Health. Panel on Understanding Cross-National Health Differences Among High-Income Countries. Washington, DC: The National Academies Press; 2013.
18. Karanikolos M, Ellis L, Coleman MP, McKee M. Health systems performance and cancer outcomes. J Natl Cancer Inst Monogr. 2013;46(1):7-12.
19. Horner MJ, Altekruse SF, Zou Z, WideroffL, Katki HA, Stinchcomb DG. U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality. Cancer Epidemiol Biomarkers Prev. 2011;20(4):591-599.
20. Gordon NP, Hiatt RA, Lampert DI. Concordance of self-reported data and medical record audit for six cancer screening procedures. J Natl Cancer Inst. 1993;85(7):566-570.
21. Francisci S, YabroffKR, Gigli A, Mariotto A, Mezzetti M, Lipscomb J. Advancing the science of cancer cost measurement: challenges and opportunities. Ann Istituto Super Sanità. 2013;49(1):73-78.
22. Butler EN, Chawla N, Lund J, Warren JL, Harlan LC, YabroffKR. Patterns of colorectal cancer care in the United States and Canada: a systematic review. J Natl Cancer Inst Monogr. 2013;46(1):13-35.
23. Chawla N, Butler EN, Lund J, Harlan LC, Warren JL, YabroffKR. Patterns of colorectal cancer care in Europe, Australia, and New Zealand. J Natl Cancer Inst Monogr. 2013;46(1):36-61.
24. YabroffKR, Borowski L, Lipscomb J. Economic studies in colorectal cancer: challenges in measuring and comparing costs. J Natl Cancer Inst Monogr. 2013;46(1)62-78.
25. Gigli A, Warren JL, YabroffKR, et al. Initial treatment for newly diagnosed elderly colorectal cancer patients: patterns of care in Italy and the United States. J Natl Cancer Inst Monogr. 2013;46(1):88-98.
26. Gatta G, Trama A, Capocaccia R. Variations in cancer survival and patterns of care across Europe: roles of wealth and health care organization. J Natl Cancer Inst Monogr. 2013;46(1):79-87.
27. Fishman PA, Hornbrook MC, Ritzwoller DP, et al. The challenge of conducting comparative effectiveness research in cancer: the impact of a fragmented US health-care system. J Natl Cancer Inst Monogr. 2013;46(1):99-105.
28. O'Keeffe-Rosetti MC, Hornbrook MC, Fishman PA, Ritzwoller DP, Lafata JE. A standardized relative resource cost model for medical care application to cancer control programs. J Natl Cancer Inst Monogr. 2013;46(1):106-116.
29. Etzioni R, Durand-Zaleski I, Lansdorp-Vogelaar I. Evaluation of new technologies for cancer control based on population trends in disease incidence and mortality. J Natl Cancer Inst Monogr. 2013;46(1):117-123.
30. Lipscomb J, YabroffKR, Hornbrook MC, et al. Comparing cancer care, outcomes and costs across health systems: charting the course. J Natl Cancer Inst Monogr. 2013;46(1):124-130.
31. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizabilty to the United States elderly population. Med Care. 2002;40(8 Suppl):IV-3-IV-18.
32. Habbema D, de Kok IM, Brown ML. Cervical cancer screening in the United States and the Netherlands: a tale of two countries. Milbank Q. 2012;90(1):5-37.
33. Verdecchia A, Francisci S, Brenner H, et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancel Oncol. 2007;8(9):784-796.
34. Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4: survival of cancer patients diagnosed in 1995-1999. Eur J Cancer. 2009;45(6): 931-991.
35. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9(8):730-756.
36. Harlan LC, Greene AL, Clegg LX, Mooney M, Stevens JL, Brown ML. Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol. 2005;23(36):9079-9088.
37. Cress RD, Bauer K, O'Malley CD, et al. Surgical staging of early stage epithelial ovarian cancer: results from the CDC-NPCR ovarian patterns of care study. Gynecol Oncol. 2011;121(1):94-99.
38. Warren JL, Barbera L, Bremner KE, et al. End-of-life care for lung cancer patients in the United States and Ontario. J Natl Cancer Inst. 2011;103(11):853-862.
39. Ho TH, Barbera L, Saskin R, Lu H, Neville BA, Earle CC. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol. 2011;29(12):1587-1591.
40. The HMO Cancer Research Network (CRN). Capacity, Collaboration, and Investigation. http://crn.cancer.gov/publications/capacity_collaboration_investigation_2010_apr.pdf. Accessed September 12, 2011.
41. Riley GF, Warren JL, Potosky AL, Klabunde CN, Harlan LC, Osswald MB. Comparison of cancer diagnosis and treatment in Medicare fee-for- service and managed care plans. Med Care. 2008;46(10):1108-1115.
42. Riley GF, Potosky AL, Lubitz JD, Brown ML. Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am J Public Health. 1994;84(10):1598-1604.
43. Surveillance Research Program. Cancer Intervention and Surveillance Modeling Network (CISNET). National Cancer Institute Web site. http://cisnet.cancer.gov. Accessed August 15, 2011.